Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 21:06 Capricor Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 18:40 Sarepta Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 17:20 Pfizer Inc. 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 21:45 Audentes Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 19:10 Solid Biosciences 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 13:05 Astellas Pharma 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 12:31 Santhera Pharmaceuticals 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 10:23 Cumberland Pharmaceuticals 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets «1…1819202122…25»Page 20 of 25
by: Parent Project Muscular Dystrophy
